Chiltern Announces Additional Investment in Endpoint
LONDON, June 16, 2011 /PRNewswire/ — Chiltern International Limited (Chiltern), a global contract research organization (CRO) announced an additional financial investment in Endpoint Clinical, Inc. (endpoint) further strengthening their strategic partnership with the company established in April 2009. Glenn Kerkhof , Chiltern CEO, stated, “Chiltern’s decision to increase our investment in …
Read more on redOrbit
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
0 Comments.